TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25384

Group type: EXPERIMENTAL
Intervention: Antacid prophylaxis (hourly titration to keep gastric pH above 3.5)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No specific form of prophylaxis (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antacid medication (for those who bled in control group)
Number of subjects: 100
Study: 30760846

Group type: EXPERIMENTAL
Intervention: Nasal spray (0.5 mL of 5% phenylephrine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 12
Study: 28289193

Group type: EXPERIMENTAL
Intervention: Artesunate treatment
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Artesunate treatment in patients with kelch13 mutant parasites
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Naturally acquired immunity
Number of subjects: 959
Study: 26343840

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics for 7 days plus standard stroke unit care
Number of subjects: 1217

Group type: COMPARATOR
Intervention: Standard stroke unit care only (control)
Number of subjects: 1217
Study: 22415440

Group type: EXPERIMENTAL
Intervention: Retro-rectus placement of non-crosslinked porcine acellular dermal matrix (Strattice™)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intraperitoneal placement of non-crosslinked porcine acellular dermal matrix (Strattice™)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (retro-rectus and intraperitoneal)
Number of subjects: 49
Study: 20934696

Group type: EXPERIMENTAL
Intervention: Pelvic Binder(®)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SAM‐Sling(®)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: T‐POD(®)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transfer to hospital bed
Number of subjects: 80
Study: 19270033

Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg daily for 7 days followed by 200 mg daily for 7 days)
Number of subjects: 20
Study: 16706692

Group type: EXPERIMENTAL
Intervention: Laser irradiation once a day for 5 days (acute gout arthritis)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Laser irradiation once a day for 21 days (chronic pyrophosphate arthropathy)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Laser irradiation once a day for 21 days (chronic hydroxyapatite arthropathy)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Diclofenac 75 mg orally, twice a day for 5 days (acute gout arthritis)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Diclofenac 50 mg orally, twice a day for 21 days (chronic pyrophosphate arthropathy)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Diclofenac 50 mg orally, twice a day for 21 days (chronic hydroxyapatite arthropathy)
Number of subjects: 104
Study: 15066943

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stenting alone (Control)
Number of subjects: 0
Study: 11103185

Group type: EXPERIMENTAL
Intervention: Propofol 6‐8 mg kg‐1 h‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane 0.8‐1.0% end tidal
Number of subjects: 30
Study: 9340238

Group type: EXPERIMENTAL
Intervention: Showering postoperatively (water contact)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Keeping the incision dry (control group)
Number of subjects: 121
Study: 8114054

Group type: EXPERIMENTAL
Intervention: Individual intensive instruction by PN teams
Number of subjects: 52

Group type: COMPARATOR
Intervention: Direct group instructions by PP teams
Number of subjects: 52
Study: 3534317

Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine (10 mg, orally twice daily for 3 days)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Carbachol (2 mg, orally twice daily for 3 days)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (orally twice daily for 3 days)
Number of subjects: 160
Study: 3076867

Group type: EXPERIMENTAL
Intervention: Tetracycline eye ointment, twice daily for five days each month for six months
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Oral doxycycline, 5 mg/kg body weight weekly for three weeks
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Oral sulphametopyrazine, 35 mg/kg body weight weekly for three weeks
Number of subjects: 368
Study: 31408773

Group type: EXPERIMENTAL
Intervention: Mindfulness practice
Number of subjects: 92

Group type: COMPARATOR
Intervention: Relaxation practice (active control)
Number of subjects: 92
Study: 28590084

Group type: EXPERIMENTAL
Intervention: 50% discount on fruits and vegetables
Number of subjects: 0
Study: 25952979

Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL) assessments
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Neurocognitive function (NCF) assessments
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiotherapy quality
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 100
Study: 23237736

Group type: EXPERIMENTAL
Intervention: Low-dose vaporized cannabis (1.29%)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Medium-dose vaporized cannabis (3.53%)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 39
Study: 22142435

Group type: EXPERIMENTAL
Intervention: Fit-4-Fun program (8-week multi-component school-based health-related fitness education intervention)
Number of subjects: 128
Study: 19737492

Group type: EXPERIMENTAL
Intervention: Drank before attending the bar
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Drank only at the bar
Number of subjects: 666
Study: 16391587

Group type: EXPERIMENTAL
Intervention: 125 microg/day (5,000 IU) of vitamin D(2)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 250 microg/day (10,000 IU) of vitamin D(2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no vitamin D(2))
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both vitamin D(2) groups (125 and 250 microg/day) combined
Number of subjects: 38
Study: 15311658

Group type: EXPERIMENTAL
Intervention: Type A masking functions with small spacings and large eccentricities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type B masking with letter-like nonletter flankers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interletter spacing and eccentricity with increasing SOA
Number of subjects: 0
Study: 11065065

Group type: EXPERIMENTAL
Intervention: Cows' milk formula (1789 infants)
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: Pasteurized human milk (1859 infants)
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: Whey hydrolysate formula (1737 infants)
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: Exclusively breast-fed (824 infants)
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: Breast-feeding during the first 8 weeks combined with infrequent exposure to small amounts of CM
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: Colostrum from mothers of infants with IgE-mediated CMA
Number of subjects: 6209

Group type: EXPERIMENTAL
Intervention: TGF-beta1 in colostrum
Number of subjects: 6209
Study: 9316509

Group type: EXPERIMENTAL
Intervention: Probucol (1,000 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no lipid-lowering therapy)
Number of subjects: 101
Study: 8403306

Group type: EXPERIMENTAL
Intervention: Ketanserin (loading dose, 40 mg 1 hour before PTCA; maintenance dose, 40 mg bid for 6 months)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 658

Group type: COMPARATOR
Intervention: Control
Number of subjects: 658
Study: 3094627

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate (active drug)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 29673395

Group type: EXPERIMENTAL
Intervention: 4-month regimen using revised WHO paediatric anti-tuberculosis drug doses
Number of subjects: 1200

Group type: COMPARATOR
Intervention: 6-month regimen using revised WHO paediatric anti-tuberculosis drug doses
Number of subjects: 1200
Study: 28606567

Group type: EXPERIMENTAL
Intervention: Wellmune 250 mg/d
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26520140

Group type: EXPERIMENTAL
Intervention: Intensive periodontal intervention involving scaling, root-planing, and removal of non-salvageable teeth, conducted over three visits (baseline, 3-month, and 6-month follow-up).
Number of subjects: 600

Group type: COMPARATOR
Intervention: Delayed intervention group receiving periodontal treatment 24 months after baseline.
Number of subjects: 600
Study: 23735703

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (PRE)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Perioperative chemotherapy (PERI)
Number of subjects: 528
Study: 20958278

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 100

Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 100
Study: 18842740

Group type: EXPERIMENTAL
Intervention: Warm touch enhancement intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Behavior monitoring control group
Number of subjects: 68
Study: 16567126

Group type: EXPERIMENTAL
Intervention: Metoprolol (mean dose 154 mg)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Metoprolol (mean dose 158 mg)
Number of subjects: 556
Study: 14565651

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim 60 microg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim 100 microg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Filgrastim 5 microg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: No cytokine treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim 100 microg/kg (balanced for risk factors)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Filgrastim (balanced for risk factors)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Filgrastim (without risk factors)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (without risk factors)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Overall incidence of febrile neutropenia
Number of subjects: 50
Study: 10425883

Group type: EXPERIMENTAL
Intervention: Klebsiella pneumoniae glycoproteins extract (1 g/day for one week a month for three months)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 7498216

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg per day)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Phenprocoumon
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (none specified)
Number of subjects: 62
Study: 2197428

Group type: EXPERIMENTAL
Intervention: Ethoglucid (0.565 gm, solution of 1%) weekly for 6 weeks, then monthly for 1 year
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Keyhole‐limpet hemocyanin (1 mg intracutaneously, then 30 mg bladder instillations weekly for 6 weeks, then monthly for 1 year)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 0
Study: 6112448

Group type: EXPERIMENTAL
Intervention: Glucose with pectin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Glucose alone
Number of subjects: 12
Study: 31701186

Group type: EXPERIMENTAL
Intervention: Hand hygiene educational intervention
Number of subjects: 717
Study: 30055359

Group type: EXPERIMENTAL
Intervention: Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Percutaneous endoscopic lumbar discectomy (PELD)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both PELD and MIS-TLIF
Number of subjects: 89
Study: 27604363

Group type: EXPERIMENTAL
Intervention: Low intensity recovery intervention using the SMART website alongside routine care
Number of subjects: 148

Group type: COMPARATOR
Intervention: Befriending (comparison condition)
Number of subjects: 148
Study: 24699062

Group type: EXPERIMENTAL
Intervention: Ketamine infusions (0.5 mg/kg over 40 minutes)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Single infusion of ketamine (0.5 mg/kg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ketamine infusions
Number of subjects: 28
Study: 22149464

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) applied to abdomen-posterior back muscles, 5 days a week for 4 weeks, 30-minute sessions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group received only physical therapy and rehabilitation (PTR) for 4 weeks
Number of subjects: 32
Study: 20798227

Group type: EXPERIMENTAL
Intervention: Hyperthyroid subjects
Number of subjects: 5080

Group type: EXPERIMENTAL
Intervention: Hypothyroid subjects
Number of subjects: 5080

Group type: EXPERIMENTAL
Intervention: Subjects with TSH<0.3 mIU/l
Number of subjects: 5080

Group type: EXPERIMENTAL
Intervention: Subjects with TSH>10 mIU/l
Number of subjects: 5080

Group type: COMPARATOR
Intervention: Euthyroid subjects
Number of subjects: 5080

Group type: EXPERIMENTAL
Intervention: TSH levels
Number of subjects: 5080
Study: 17700388

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg weekly
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg weekly
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg weekly
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg every other week
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg every other week
Number of subjects: 18
Study: 16135896

Group type: EXPERIMENTAL
Intervention: 200 mg QD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 200 mg BID
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 400 mg QD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 600 mg BID
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11906322

Group type: EXPERIMENTAL
Intervention: 1200 mg thioctic acid
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine 600 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 9678312

Group type: EXPERIMENTAL
Intervention: Oculomotor testing (electro-oculography)
Number of subjects: 26
Study: 8206687

Group type: EXPERIMENTAL
Intervention: poly(A).poly(U)
Number of subjects: 19
Study: 2541740

Group type: EXPERIMENTAL
Intervention: Converting‐enzyme inhibitor (CEI)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 77
Study: 4837835

Group type: EXPERIMENTAL
Intervention: Physical training (3 sessions/week for 3 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference group (no training)
Number of subjects: 26
Study: 29551330

Group type: EXPERIMENTAL
Intervention: increase moderate to vigorous physical activity (MVPA) treatment group
Number of subjects: 204

Group type: COMPARATOR
Intervention: decrease sedentary behavior control group
Number of subjects: 204
Study: 28070018

Group type: EXPERIMENTAL
Intervention: Curcumin (2000 mg/day Longvida®; n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (n=19)
Number of subjects: 39
Study: 26202452

Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 304

Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 304

Group type: COMPARATOR
Intervention: Combined training
Number of subjects: 304
Study: 23286591

Group type: EXPERIMENTAL
Intervention: TPB plus implementation intentions intervention
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: TPB-only intervention
Number of subjects: 739
Study: 21861995

Group type: EXPERIMENTAL
Intervention: IRIS (Iterative Reconstruction in Image Space)
Number of subjects: 90

Group type: COMPARATOR
Intervention: IRIS in group B (100 kV/110 mAs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: IRIS in group C (120 kV/67 mAs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: FBP (Filtered Back-Projection) in group A (120 kV/110 mAs)
Number of subjects: 90
Study: 19091804

Group type: EXPERIMENTAL
Intervention: PSST + PDA 8-week program
Number of subjects: 197

Group type: COMPARATOR
Intervention: Traditional PSST 8-week program
Number of subjects: 197
Study: 16680924

Group type: EXPERIMENTAL
Intervention: Montelukast (5 or 10 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 15293489

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 20
Study: 11531751

Group type: EXPERIMENTAL
Intervention: Non-contrast computed tomography (NCCT)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Intravenous urography (IVU)
Number of subjects: 224
Study: 9038591

Group type: EXPERIMENTAL
Intervention: Exogenous insulin (50 m-units h-1 kg-1) for 4 hours
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (8 subjects)
Number of subjects: 13
Study: 8590112

Group type: EXPERIMENTAL
Intervention: Intensive, team-based case management program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard psychiatric services
Number of subjects: 40
Study: 2766180

Group type: EXPERIMENTAL
Intervention: Feedback from a nurse or physician (type of feedback)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Feedback (any type)
Number of subjects: 175
Study: 1000140

Group type: EXPERIMENTAL
Intervention: Aversive therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive conditioning procedure
Number of subjects: 0
Study: 30378448

Group type: EXPERIMENTAL
Intervention: Social Tools And Rules for Teens intervention
Number of subjects: 35

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 35
Study: 29223441

Group type: EXPERIMENTAL
Intervention: Edoxaban 15 mg once daily
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study: 24884948

Group type: EXPERIMENTAL
Intervention: Meniscectomy surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo surgery
Number of subjects: 40
Study: 22699104

Group type: EXPERIMENTAL
Intervention: High-dosage CIMT (6 hours/day for 21 days, total 126 hours)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Moderate-dosage CIMT (3 hours/day for 21 days, total 63 hours)
Number of subjects: 18
Study: 19727781

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltration onto the neural root
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no bupivacaine infiltration)
Number of subjects: 51
Study: 18541549

Group type: EXPERIMENTAL
Intervention: Protein diet
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: All 3 diets
Number of subjects: 162
Study: 15836941

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 82

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 82
Study: 12088951

Group type: EXPERIMENTAL
Intervention: Intraoperative small-dose ketamine (0.15 mg/kg followed by 2 microg. kg(‐1). min(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study: 10334526

Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m2 i.v. every 3 weeks (n=203)
Number of subjects: 392

Group type: COMPARATOR
Intervention: Mitomycin 12 mg/m2 i.v. every 6 weeks plus vinblastine 6 mg/m2 i.v. every 3 weeks (n=189)
Number of subjects: 392
Study: 7604138

Group type: EXPERIMENTAL
Intervention: Nicergoline (2 x 30 mg)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo (2 x 1)
Number of subjects: 112
Study: 2122821

Group type: EXPERIMENTAL
Intervention: TPN supplemented with alanyl‐glutamine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional TPN without alanyl‐glutamine
Number of subjects: 16
Study: 686848

Group type: EXPERIMENTAL
Intervention: Room air plus machine‐produced cigarette smoke
Number of subjects: 20

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 20
Study: 30449156

Group type: EXPERIMENTAL
Intervention: 6-minute walking test (6MWT)
Number of subjects: 0
Study: 28121177

Group type: EXPERIMENTAL
Intervention: Elastic tape (Kinesio tape)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 51
Study: 25911172

Group type: EXPERIMENTAL
Intervention: 7 day bladder catheterisation
Number of subjects: 524

Group type: COMPARATOR
Intervention: 14 day bladder catheterisation
Number of subjects: 524
Study: 23547816

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 31
Study: 21993319

Group type: EXPERIMENTAL
Intervention: Preoperative CT scan
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous urography and renal ultrasonography (no CT scan)
Number of subjects: 50
Study: 19192084

Group type: EXPERIMENTAL
Intervention: Psychiatric mental health nursing interventions
Number of subjects: 25
Study: 16239317

Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation with GnRH antagonist co-treatment and transfer of one embryo
Number of subjects: 410

Group type: COMPARATOR
Intervention: Conventional stimulation with GnRH agonist long protocol co-treatment and transfer of two embryos
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation
Number of subjects: 410

Group type: COMPARATOR
Intervention: Conventional stimulation
Number of subjects: 410
Study: 15605332

Group type: EXPERIMENTAL
Intervention: Functional tasks exercise program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resistance exercise program
Number of subjects: 24
Study: 11377349

Group type: EXPERIMENTAL
Intervention: Dofetilide (8 microg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amiodarone (5 mg/kg)
Number of subjects: 30
Study: 9005747

Group type: EXPERIMENTAL
Intervention: 10-mg loading dose of warfarin
Number of subjects: 49

Group type: COMPARATOR
Intervention: 5-mg loading dose of warfarin
Number of subjects: 49
Study: 7984597

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Patients with pulmonary tuberculosis
Number of subjects: 32
Study: 3544286

Group type: EXPERIMENTAL
Intervention: Radioimmunochemotherapy using nimustine hydrochloride (ACNU) plus Picibanil (OK‐432) (group A)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Radiochemotherapy with ACNU only (group B)
Number of subjects: 51
Study: 31754787

Group type: EXPERIMENTAL
Intervention: Five-hour RA basic education program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Train-the-trainer training courses
Number of subjects: 0
Study: 29898853

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 17160

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 17160
Study: 27978942

Group type: EXPERIMENTAL
Intervention: NOAC overdosing
Number of subjects: 5738

Group type: EXPERIMENTAL
Intervention: NOAC underdosing
Number of subjects: 5738

Group type: COMPARATOR
Intervention: Recommended NOAC doses
Number of subjects: 5738